Clinical TrialsSearch results
Number of results: 337
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- A phase II Study of CBDCA + ETP + Nintedanib for SCLC with IPF
- Unresectable limited or extensive disease small cell lung cancer with idiopathic pulmonary fibrosis
- IKEDA Satoshi
- 2019-10-18
Other
- A phase I/II study of transarterial chemoembolization with cisplatin for hepatocellular carcinoma (JIVROSG-0401)
- Unresectable hypervascular hepatocellular carcinoma
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-07
Other
- Phase2/3 Study of OTS102 in Combination With Gemcitabine in Patients With Unresectable Advanced Pancreatic Cancer and Recurrent Pancreatic Cancer(PEGASUS-PC Study)
- Unresectable Advanced and Recurrent Pancreatic Cancer
- OncoTherapy Science, Inc.
- 2009-01-27
Other
- Establishment of surveillance system for the longstanding ulcerative colitis patients Comparative study of efficacy for the targeted biopsy and the step biopsy
- Ulcerative colitis
- Teikyo University School of Medicine
- 2009-01-05
Completed
- Efficacy of empagliflozin to type 2 diabetic patients with ICD
- Type2 Diabetes
- Minamino Tohru
- 2019-02-15
Other
- Clinical study of combinational therapy of AD-4833 with metformin -Phase III double-blind comparative study-
- Type2 Diabetes
- Takeda Pharmaceutical Company Limited
- 2008-04-04
Other
- Effect of Tofogliflozin on Urine Albumin-to-Creatinine Ratio Compared to Metformin Hydrochloride in Diabetic Kidney Disease
- Type 2 Diabetes Mellitus, Chronic Kidney Disease
- Kuwahara Koichiro
- 2021-09-22
Recruiting
- Feasibility study of a smartphone application in type 2 diabetes with stage 2 diabetic nephropathy
- Type 2 diabetes mellitus with stage 2 diabetic nephropathy
- Hirohito Sone
- 2024-03-05
Recruiting
- A Randomized Controlled Trial of the Efficacy of Blood Glucose and Diet and Physical Activity Monitoring
- type 2 diabetes mellitus
- Hirohito Sone
- 2021-12-21
Completed
- A randomized controlled trial of Ipragliflozin and sitagliptin
- Type 2 diabetes
- Sone Hirohito
- 2019-03-07